How the aging thymus repairs itself after injury
Response of aged thymus to injury and rejuvenation signals
Researchers are working to boost the aging thymus's ability to recover after damage from infections or cancer treatments in older people.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-11308362 on NIH RePORTER |
What this research studies
This project aims to understand why the thymus heals less well as we age. Researchers will compare repair processes in young versus old animals, examine sex differences across the lifespan, and study the cellular signals that promote or block regeneration after acute damage. They will focus on the balance between inflammatory signals from dying cells and pro-regenerative signals, and test known and new therapies in aged mice to find approaches that restore thymus function. Findings are intended to inform treatments that help older patients regain immune strength after infection, chemotherapy, or stem-cell transplant.
Who could benefit from this research
Good fit: Older adults who have weakened immune recovery after cytoreductive cancer therapy or who are undergoing conditioning for hematopoietic stem-cell transplant would be the most relevant group.
Not a fit: People whose immune problems come from genetic immune deficiencies or conditions unrelated to age-related thymic decline are unlikely to benefit from these thymus-focused approaches.
Why it matters
Potential benefit: Could lead to therapies that restore or speed immune recovery in older adults after cancer treatments or transplant conditioning.
How similar studies have performed: Prior animal work has shown the thymus can regenerate and that certain signals can improve repair, but translating those approaches to aged thymus tissue remains an active and partly novel area.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Dudakov, Jarrod — University of Arizona
- Study coordinator: Dudakov, Jarrod
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.